A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for cycloserine in 50μL of human plasma: Its pharmacokinetic application

Journal of Pharmaceutical and Biomedical Analysis

Volumn 76, Issue , 2013, Pages 21-27

  Polagani, Srinivasa Rao ^a,b   Pilli, Nageswara Rao ^b   Maddela, Rambabu ^b   Gajula, Ramakrishna ^b   Gandu, Venkateswarlu ^c  

^a RAYALASEEMA UNIVERSITY   (India)

^b Wellquest Clinical Research   (India)

^c OSMANIA UNIVERSITY   (India)

Author keywords

Cycloserine in human plasma; Liquid chromatography tandem mass spectrometry; Method validation; Pharmacokinetic studies; Protein precipitation (PP)

Indexed keywords

ACETONITRILE; CARBAMAZEPINE; CYCLOSERINE;

ADULT; ARTICLE; FLOW RATE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANTIBIOTICS, ANTITUBERCULAR; CALIBRATION; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSERINE; GUIDELINES AS TOPIC; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84872042418     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.11.036     Document Type: Article

References (15)

1. David S. Synergic activity of d-cycloserine and beta-chloro-d-alanine against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2001, 47:203-206.
2. Antibiotic and Chemotherapy 2002, 11-35. Churchill Livingstone, New York. 8th ed. R.G. Finch, D. Greenwood, S.R. Norrby, R.J. Whitley (Eds.).
3. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 2003, 111:1265-1273.
4. Abbanat D., Macielag M., Bush K. Novel antibacterial agents for the treatment of serious Gram-positive infections. Expert Opin. Investig. Drugs 2003, 12:379-399.
5. Neuhhaus F.C. Antibiotics. I. Mechanism of Action 1967, 40-83. Springer-Verlag, Berlin, Heidelberg, New York. D. Gottlieb, P.D. Shaw (Eds.).
6. Scotto P., Monaco P., Scardi V., Bonavita V. Neurochemical studies with l-cycloserine, a central depressant agent. J. Neurochem. 1963, 10:831-839.
7. Patel D.S., Sharma N., Patel M.C., Patel B.N., Shrivastav P.S., Sanyal M. Development and validation of a selective and sensitive LC-MS/MS method for determination of cycloserine in human plasma: application to bioequivalence study. J. Chromatogr. B 2011, 879:2265-2273.
8. Pesek J.J., Matyska M.T., Dang A. Analysis of cycloserine and related compounds using aqueous normal phase chromatography/mass spectrometry. J. Pharm. Biomed. Anal. 2012, 64/65(64):72-80.
9. Karthikeyan K., Arularasu G.T., Ramadhas R., Pillai K.C. Development and validation of indirect RP-HPLC method for enantiomeric purity determination of d-cycloserine drug substance. J. Pharm. Biomed. Anal. 2011, 850:850-854.
10. Pendela M., Dragovic S., Bockx L., Hoogmartens J., Van Schepdael A., Adams E. Development of a liquid chromatographic method for the determination of related substances and assay of d-cycloserine. J. Pharm. Biomed. Anal. 2008, 47:807-811.
11. David V., Ionescu M., Dumitrescu V. Determination of cycloserine in human plasma by high-performance liquid chromatography with fluorescence detection, using derivatization with p-benzoquinone. J. Chromatogr. B 2001, 761:27-33.
12. Musson D.G., Maglietto S.M., Hwang S.S., Gravellese D., Bayne W.F. Simultaneous quantification of cycloserine and its prodrug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization. J. Chromatogr. 1987, 414:121-129.
13. US DHHS, FDA, CDER. Guidance for Industry: Bioanalytical Method Validation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CV), 2001. Available at: http://www/fda.gov/cder/guidance/index.htm.
14. Fast D.M., Kelley M., Viswanathan C.T. Workshop report and follow-up-AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples-implications of crystal city recommendations. AAPS J. 2009, 11:238-241.
15. Karra V.K., Pilli N.R., Polagani S.R., Inamadugu J.K., Seshagiri Rao J.V. Liquid chromatography-tandem mass spectrometric assay for the light sensitive calcium channel antagonist lacidipine in human plasma. J. Pharm. Biomed. Anal. 2012, 66:211-217.